Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Bekzat, Astana, Kazakhstan
Bekzat, Astana, Kazakhstan
Bekzat, Astana, Kazakhstan
Asan Medical Center, Seoul, Korea, Republic of
Tongji Hospital, Wuhan, Hubei, China
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Department of Anesthesiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.